FactSet is in a sustained recovery uptrend that has carried the stock from a 52-week low of $185.00 to a current price of $301.67, a gain of 8.51% over the trailing year that nonetheless trails the S&P 500's 15.53% advance, producing a relative strength reading of -7.02 over 12 months. At $301.67 the shares sit roughly 94.1% of the way through the $185.00-$320.48 52-week range, a positioning that signals momentum leadership but also meaningful proximity to overextension, particularly with the all-time-range high only about 6.2% above the current quote. The stock's max drawdown of -48.7% underscores that this recovery follows a severe prior de-rating, so the uptrend is rebuilding rather than extending an uninterrupted multi-year advance. Short-term momentum is clearly accelerating: the stock is up 9.14% over the past month, 16.89% over three months, and 29.62% over six months, with the 1-month relative strength of +7.92 versus the S&P's +1.22% confirming genuine outperformance rather than beta-driven drift. This creates a notable divergence with the 1-year relative strength of -7.02, implying the stock spent the first half of the trailing year lagging badly before a powerful second-half reversal; the 3-month and 6-month relative strength readings of +14.20 and +22.14 show the turn is well established rather than a one-week bounce. The most recent session was essentially flat (-0.05%, from $301.83 to $301.67) on volume of 571,960 shares, suggesting consolidation at the highs rather than distribution, though RSI is not provided and should be checked for overbought conditions after a 29.6% six-month run. Key resistance sits at the $320.48 52-week high, roughly 6.2% above spot; a decisive breakout would confirm the recovery as a new leg higher and likely force short covering given a short ratio of 3.54 days. Support is anchored by the $185.00 52-week low, but more relevant near-term support lies in the $260-$270 zone where the September pullback found buyers (the stock bottomed at $259.71 on September 11 before rebounding). With a beta of 0.766, FactSet is roughly 23% less volatile than the market, which argues for larger position sizing per unit of expected return but also means the recent 29.6% six-month move is unusually large for this name and raises mean-reversion risk.

Revenue is growing at a steady but unspectacular pace: fiscal Q4 2026 revenue of $634.70 million rose 6.33% year over year from $596.90 million, continuing a multi-quarter cadence of roughly 6-7% growth (Q3 $622.92 million, Q2 $611.02 million, Q1 $607.62 million versus $585.52 million, $570.66 million, and $568.67 million in the prior-year quarters). Sequentially, revenue has climbed every quarter of fiscal 2026, and the segment mix shows the Americas at $407.24 million (about 65% of the $622.9 million quarterly base), EMEA at $151.94 million, and Asia Pacific at $63.74 million, meaning growth is heavily levered to the U.S. buy-side wallet. The trajectory implies a low-double-digit-to-high-single-digit compounder rather than a re-accelerating growth story, which is consistent with consensus revenue of $3.233 billion and explains why the stock's re-rating has been multiple-driven rather than estimate-driven. Profitability remains robust but is compressing at the margin: Q4 net income of $121.13 million produced a 19.08% net margin, down from 25.74% in the year-ago quarter, while gross margin fell to 48.59% from 51.64% a year earlier and operating margin contracted to 24.68% from 29.71%. The full-year picture is better than the exit quarter, with a 21.54% net margin and 28.27% operating margin on a TTM basis, but the direction of travel is clear: Q1 2026 gross margin was 52.62% and Q2 51.43%, deteriorating to 49.88% in Q3 and 48.59% in Q4, a roughly 400bp decline across the fiscal year that points to rising data costs, AI infrastructure spend, or mix shift. EPS still grew to $3.42 in Q4 from $4.07 a year ago on a GAAP basis (down, reflecting the margin squeeze and higher interest expense of $14.40 million), and the company remains solidly profitable with a 26.65% ROE, so this is a margin-durability question rather than a solvency one. The balance sheet is the weakest part of the story: the current ratio of 0.599 is well below 1.0, meaning current liabilities exceed current assets, and debt-to-equity of 0.770 combined with cash of only $239.6 million at quarter-end leaves limited liquidity cushion. Cash generation is nonetheless strong, with TTM free cash flow of $707.48 million (FCF per share of $5.01) and Q4 operating cash flow of $204.71 million against capex of just $27.40 million, a capital-light model that funds growth internally. Management is returning essentially all of that cash to shareholders, repurchasing $137.96 million of stock in Q4 alone and paying $41.50 million in dividends, which explains the thin cash balance; the dividend yield of 1.44% with a 30.8% payout ratio is well covered, and the FCF yield of roughly 6.2% on the $11.43 billion market cap is respectable for a data moat business, though the sub-1.0 current ratio and 0.77 D/E mean external financing flexibility, not internal liquidity, is the backstop.